title: Successful treatment with imatinib mesylate in a case of chronic myeloproliferative disorder with a t(5;12)(q33;p13.1) without eosinophilia.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Nadal
authors.forename: Pascale
authors.initials: P
authors.lastname: Flandrin
authors.forename: Jerome
authors.initials: J
authors.lastname: Cornillon
authors.forename: Eric
authors.initials: E
authors.lastname: Delabesse
authors.forename: Laurent
authors.initials: L
authors.lastname: Mauvieux
authors.forename: Daniela
authors.initials: D
authors.lastname: Olaru
authors.forename: Sylvie
authors.initials: S
authors.lastname: Morel
authors.forename: Lydia
authors.initials: L
authors.lastname: Campos
mesh_terms: D001549:Benzamides; D002881:Chromosomes, Human, Pair 12; D002895:Chromosomes, Human, Pair 5; D002908:Chronic Disease; D004802:Eosinophilia / Q000175:diagnosis; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D014178:Translocation, Genetic
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate